Simon Says Immunotherapy Combo Regimens on Horizon in NSCLC
Published: Monday, Dec 04, 2017
George R. Simon, MD
Immunotherapy continues to show single-agent efficacy in non–small cell lung cancer (NSCLC) and is now being investigated in combination regimens to further improve patient outcomes.
... to read the full story